Literature DB >> 22752616

The International Serious Adverse Events Consortium (iSAEC) phenotype standardization project for drug-induced torsades de pointes.

Elijah R Behr1, Craig January, Eric Schulze-Bahr, Andrew A Grace, Stefan Kääb, Monica Fiszman, Shaniece Gathers, Shaavhrée Buckman, Ashraf Youssef, Munir Pirmohamed, Dan Roden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22752616      PMCID： PMC3703308          DOI： 10.1093/eurheartj/ehs172

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  22 in total

Review 1.  Drug induced QT prolongation and torsades de pointes.

Authors:  Yee Guan Yap; A John Camm
Journal:  Heart       Date:  2003-11       Impact factor: 5.994

2.  "Late" proarrhythmia due to quinidine.

Authors:  K C Oberg; M F O'Toole; J L Gallastegui; J L Bauman
Journal:  Am J Cardiol       Date:  1994-07-15       Impact factor: 2.778

3.  Common variation in the NOS1AP gene is associated with drug-induced QT prolongation and ventricular arrhythmia.

Authors:  Yalda Jamshidi; Ilja M Nolte; Chrysoula Dalageorgou; Dongling Zheng; Toby Johnson; Rachel Bastiaenen; Suzanne Ruddy; Daniel Talbott; Kris J Norris; Harold Snieder; Alfred L George; Vanessa Marshall; Saad Shakir; Prince J Kannankeril; Patricia B Munroe; A John Camm; Steve Jeffery; Dan M Roden; Elijah R Behr
Journal:  J Am Coll Cardiol       Date:  2012-06-06       Impact factor: 24.094

4.  KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome.

Authors:  C Donger; I Denjoy; M Berthet; N Neyroud; C Cruaud; M Bennaceur; G Chivoret; K Schwartz; P Coumel; P Guicheney
Journal:  Circulation       Date:  1997-11-04       Impact factor: 29.690

Review 5.  Long QT syndromes and torsade de pointes.

Authors:  S Viskin
Journal:  Lancet       Date:  1999-11-06       Impact factor: 79.321

Review 6.  Torsade de pointes due to noncardiac drugs: most patients have easily identifiable risk factors.

Authors:  David Zeltser; Dan Justo; Amir Halkin; Vitaly Prokhorov; Karin Heller; Sami Viskin
Journal:  Medicine (Baltimore)       Date:  2003-07       Impact factor: 1.889

7.  Torsade de pointes: the long-short initiating sequence and other clinical features: observations in 32 patients.

Authors:  G N Kay; V J Plumb; J G Arciniegas; R W Henthorn; A L Waldo
Journal:  J Am Coll Cardiol       Date:  1983-11       Impact factor: 24.094

8.  Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients.

Authors:  Aimée D C Paulussen; Ronaldus A H J Gilissen; Martin Armstrong; Pieter A Doevendans; Peter Verhasselt; Hubert J M Smeets; Eric Schulze-Bahr; Wilhelm Haverkamp; Günter Breithardt; Nadine Cohen; Jeroen Aerssens
Journal:  J Mol Med (Berl)       Date:  2004-02-04       Impact factor: 4.599

9.  Incidence and clinical features of the quinidine-associated long QT syndrome: implications for patient care.

Authors:  D M Roden; R L Woosley; R K Primm
Journal:  Am Heart J       Date:  1986-06       Impact factor: 4.749

10.  Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia.

Authors:  Igor Splawski; Katherine W Timothy; Michihiro Tateyama; Colleen E Clancy; Alka Malhotra; Alan H Beggs; Francesco P Cappuccio; Giuseppe A Sagnella; Robert S Kass; Mark T Keating
Journal:  Science       Date:  2002-08-23       Impact factor: 47.728
View more
  9 in total

Review 1.  Biomarkers of adverse drug reactions.

Authors:  Daniel F Carr; Munir Pirmohamed
Journal:  Exp Biol Med (Maywood)       Date:  2017-09-26

Review 2.  Drug-induced arrhythmia: pharmacogenomic prescribing?

Authors:  Elijah R Behr; Dan Roden
Journal:  Eur Heart J       Date:  2012-10-22       Impact factor: 29.983

Review 3.  The genetics of pro-arrhythmic adverse drug reactions.

Authors:  Evmorfia Petropoulou; Yalda Jamshidi; Elijah R Behr
Journal:  Br J Clin Pharmacol       Date:  2014-04       Impact factor: 4.335

Review 4.  Predicting drug-induced QT prolongation and torsades de pointes.

Authors:  Dan M Roden
Journal:  J Physiol       Date:  2016-01-18       Impact factor: 5.182

Review 5.  Advances in the Pharmacogenomics of Adverse Drug Reactions.

Authors:  Susannah L Collins; Daniel F Carr; Munir Pirmohamed
Journal:  Drug Saf       Date:  2016-01       Impact factor: 5.606

Review 6.  Drug-induced liver injury: Towards early prediction and risk stratification.

Authors:  Emanuel Raschi; Fabrizio De Ponti
Journal:  World J Hepatol       Date:  2017-01-08

7.  Pharmacogenomics: Current State-of-the-Art.

Authors:  Daniel F Carr; Ana Alfirevic; Munir Pirmohamed
Journal:  Genes (Basel)       Date:  2014-05-26       Impact factor: 4.096

8.  Phenotype standardization for statin-induced myotoxicity.

Authors:  A Alfirevic; D Neely; J Armitage; H Chinoy; R G Cooper; R Laaksonen; D F Carr; K M Bloch; J Fahy; A Hanson; Q-Y Yue; M Wadelius; A H Maitland-van Der Zee; D Voora; B M Psaty; C N A Palmer; M Pirmohamed
Journal:  Clin Pharmacol Ther       Date:  2014-06-04       Impact factor: 6.875

Review 9.  Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity.

Authors:  L McEvoy; D F Carr; M Pirmohamed
Journal:  Front Pharmacol       Date:  2021-06-21       Impact factor: 5.810
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.